A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
The purpose of the study is to demonstrate the efficacy and safety, and to assess the pharmacokinetics of adalimumab administered subcutaneously (SC) in pediatric subjects with moderate to severe ulcerative colitis (UC).
Inclusion Criteria:
Exclusion Criteria:
Kurume-shi, Fukuoka 830-0011, Japan
Nishinomiya-shi, Hyōgo 663-8501, Japan
Saitama-shi, Saitama 330-8777, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Setagaya-ku, Tokyo 157-8535, Japan